This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We have now added a new section called the "Assay History List" to the "At A Gla...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...